| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.5 |
| mRNA | GDC-0449 | FIMM | pan-cancer | AAC | 0.13 | 0.5 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | manumycin A | CTRPv2 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | Salubrinal | GDSC1000 | pan-cancer | AAC | 0.035 | 0.5 |